The Food and Drug Administration conducted an inspection of Versiti Indiana, Inc. in Hilliard on April 23, reviewing the organization’s blood and blood product practices, according to data posted on the FDA’s website.
Inspection findings showed that Versiti Indiana, Inc. was not required to make any changes to its management operations.
The FDA routinely inspects facilities nationwide to confirm that workplaces and products meet FDA regulations intended to protect public health. Results from these inspections are made available to the public.
According to its website, the FDA is a federal agency charged with regulating the safety and quality of drugs, biological products, medical devices and tobacco products for both humans and animals.
Information in this article was obtained from the U.S. Food and Drug Administration. The source data can be found here.
